A possible way to improve the glycaemic control and the beta cell function during three years: the triple therapy
Latest Information Update: 18 Apr 2013
At a glance
- Drugs Glibenclamide (Primary) ; Sitagliptin (Primary) ; Metformin; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Oct 2012 New trial record
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.